effect < effective < effectively

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f

List of bibliographic references

Number of relevant bibliographic references: 44.
[0-20] [0 - 20][0 - 44][20-40]

Ident.	Authors (with country if any)	Title
000012 (2020)	F. Yang [République populaire de Chine] ; N. Liu ; J Y Hu ; L L Wu ; G S Su ; N S Zhong ; Z G Zheng	[Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)].
000014 (2020)	H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine]	[Potential antiviral therapeutics for 2019 Novel Coronavirus].
000029 (2020)	Y. Si [République populaire de Chine] ; X F Sun [République populaire de Chine] ; M. Zhong [République populaire de Chine] ; J N Yue [République populaire de Chine] ; W G Fu [République populaire de Chine]	[Countermeasures and treatment for aortic acute syndrome with 2019 coronavirus disease].
000041 (2020)	J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine]	[Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].
000067 (2020)	Haiou Li [République populaire de Chine] ; Yunjiao Zhou [République populaire de Chine] ; Meng Zhang [République populaire de Chine] ; Haizhou Wang [République populaire de Chine] ; Qiu Zhao [République populaire de Chine] ; Jing Liu [République populaire de Chine]	Updated approaches against SARS-CoV-2.
000069 (2020)	Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela]	Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target
000092 (2020)	Robert L. Kruse [États-Unis]	Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000102 (2020)	Weilong Shang ; Yi Yang ; Yifan Rao ; Xiancai Rao	The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
000105 (2020)	Raquel Martins Lana [Brésil] ; Flávio Codeço Coelho [Brésil] ; Marcelo Ferreira Da Costa Gomes [Brésil] ; Oswaldo Gonçalves Cruz [Brésil] ; Leonardo Soares Bastos [Brésil] ; Daniel Antunes Maciel Villela [Brésil] ; Cláudia Torres Codeço [Brésil]	The novel coronavirus (SARS-CoV-2) emergency and the role of timely and effective national health surveillance.
000106 (2020)	Dana Rose Garfin ; Roxane Cohen Silver ; E Alison Holman	The novel coronavirus (COVID-2019) outbreak: Amplification of public health consequences by media exposure.
000115 (2020)	Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]	The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000141 (2020)	Dandan Wu [République populaire de Chine] ; Xuexian O. Yang [États-Unis]	TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib.
000187 (2020)	Hao Yu ; Xu Sun ; Wei Deng Solvang ; Xu Zhao	Reverse Logistics Network Design for Effective Management of Medical Waste in Epidemic Outbreaks: Insights from the Coronavirus Disease 2019 (COVID-19) Outbreak in Wuhan (China)
000232 (2020)	Yu Wai Chen [Hong Kong] ; Chin-Pang Bennu Yiu [Hong Kong] ; Kwok-Yin Wong [Hong Kong]	Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
000255 (2020)	G. Kampf [Allemagne] ; D. Todt [Allemagne] ; S. Pfaender [Allemagne] ; E. Steinmann [Allemagne]	Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
000278 (2020)	Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis]	Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
000310 (2020)	Xingchen Pan [République populaire de Chine] ; David M. Ojcius [États-Unis] ; Tianyue Gao [Canada] ; Zhongsheng Li [République populaire de Chine] ; Chunhua Pan [République populaire de Chine] ; Chungen Pan [République populaire de Chine]	Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases.
000331 (2020)	Muh-Yong Yen [Taïwan] ; Jonathan Schwartz [États-Unis] ; Shey-Ying Chen [Taïwan] ; Chwan-Chuen King [Taïwan] ; Guang-Yang Yang [Taïwan] ; Po-Ren Hsueh [Taïwan]	Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts.
000354 (2020)	Jia Liu [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Xi Wang [République populaire de Chine] ; Huanyu Zhang [République populaire de Chine] ; Hengrui Hu [République populaire de Chine] ; Yufeng Li [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Manli Wang [République populaire de Chine]	Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
000374 (2020)	Chih-Cheng Lai [Taïwan] ; Cheng-Yi Wang [Taïwan] ; Ya-Hui Wang [Taïwan] ; Shun-Chung Hsueh [Taïwan] ; Wen-Chien Ko [Taïwan] ; Po-Ren Hsueh [Taïwan]	Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status.
000399 (2020)	Yixiang Ng ; Zongbin Li ; Yi Xian Chua ; Wei Liang Chaw ; Zheng Zhao ; Benjamin Er ; Rachael Pung ; Calvin J. Chiew ; David C. Lye ; Derrick Heng ; Vernon J. Lee	Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i -k "effective" 

HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i  \
                -Sk "effective" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    new
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    effective
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021